These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 29906527)

  • 1. Induction of bystander tolerance and immune deviation after Fel d 1 peptide immunotherapy.
    Moldaver DM; Bharhani MS; Rudulier CD; Wattie J; Inman MD; Larché M
    J Allergy Clin Immunol; 2019 Mar; 143(3):1087-1099.e4. PubMed ID: 29906527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotype analyses of IL-10-producing Foxp3
    Matsuda M; Morie Y; Oze H; Doi K; Tsutsumi T; Hamaguchi J; Inaba M; Nabe T
    Int Immunopharmacol; 2018 Aug; 61():297-305. PubMed ID: 29909233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intranasal ovalbumin immunotherapy with mycobacterial adjuvant promotes regulatory T cell accumulation in lung tissues.
    Akkoç T; Genç D; Zibandeh N; Akkoç T
    Microbiol Immunol; 2018 Aug; 62(8):531-540. PubMed ID: 29989252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD4+CD25-mTGFbeta+ T cells induced by nasal application of ovalbumin transfer tolerance in a therapeutic model of asthma.
    Pellaton-Longaretti C; Boudousquié C; Barbier N; Barbey C; Argiroffo CB; Donati Y; Sauty A; Spertini F
    Int Immunol; 2011 Jan; 23(1):17-27. PubMed ID: 21123830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic cat allergen exposure induces a TH2 cell-dependent IgG4 response related to low sensitization.
    Renand A; Archila LD; McGinty J; Wambre E; Robinson D; Hales BJ; Thomas WR; Kwok WW
    J Allergy Clin Immunol; 2015 Dec; 136(6):1627-1635.e13. PubMed ID: 26371841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of CRTh2 expression on allergen-specific T cells following peptide immunotherapy.
    Rudulier CD; Tonti E; James E; Kwok WW; Larché M
    Allergy; 2019 Nov; 74(11):2157-2166. PubMed ID: 31077596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The major cat allergen, Fel d 1, in diagnosis and therapy.
    Grönlund H; Saarne T; Gafvelin G; van Hage M
    Int Arch Allergy Immunol; 2010; 151(4):265-74. PubMed ID: 19844127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A role for IL-10-mediated HLA-DR7-restricted T cell-dependent events in development of the modified Th2 response to cat allergen.
    Reefer AJ; Carneiro RM; Custis NJ; Platts-Mills TA; Sung SS; Hammer J; Woodfolk JA
    J Immunol; 2004 Mar; 172(5):2763-72. PubMed ID: 14978075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microneedle-Mediated Allergen-Specific Immunotherapy for the Treatment of Airway Allergy in Mice.
    Shakya AK; Lee CH; Gill HS
    Mol Pharm; 2020 Aug; 17(8):3033-3042. PubMed ID: 32643940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Covalent coupling of vitamin D3 to the major cat allergen Fel d 1 improves the effects of allergen-specific immunotherapy in a mouse model for cat allergy.
    Grundström J; Neimert-Andersson T; Kemi C; Nilsson OB; Saarne T; Andersson M; van Hage M; Gafvelin G
    Int Arch Allergy Immunol; 2012; 157(2):136-46. PubMed ID: 21985799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cat allergen peptide immunotherapy reduces CD4(+) T cell responses to cat allergen but does not alter suppression by CD4(+) CD25(+) T cells: a double-blind placebo-controlled study.
    Smith TR; Alexander C; Kay AB; Larché M; Robinson DS
    Allergy; 2004 Oct; 59(10):1097-101. PubMed ID: 15355469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune regulation by intralymphatic immunotherapy with modular allergen translocation MAT vaccine.
    Zaleska A; Eiwegger T; Soyer O; van de Veen W; Rhyner C; Soyka MB; Bekpen C; Demiröz D; Treis A; Söllner S; Palomares O; Kwok WW; Rose H; Senti G; Kündig TM; Ozoren N; Jutel M; Akdis CA; Crameri R; Akdis M
    Allergy; 2014 Sep; 69(9):1162-70. PubMed ID: 24934402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transfer of T cells from intranasal ovalbumin-immunized mice ameliorates allergic response in ova-sensitized recipient mice.
    Akkoc T; Eifan AO; Aydogan M; Ozkara S; Bahceciler NN; Barlan IB
    Allergy Asthma Proc; 2008; 29(4):411-6. PubMed ID: 18341761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigen Uptake by Langerhans Cells Is Required for the Induction of Regulatory T Cells and the Acquisition of Tolerance During Epicutaneous Immunotherapy in OVA-Sensitized Mice.
    Dioszeghy V; Mondoulet L; Laoubi L; Dhelft V; Plaquet C; Bouzereau A; Dupont C; Sampson H
    Front Immunol; 2018; 9():1951. PubMed ID: 30233572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipopolysaccharides modulate allergen-specific immune regulation in a murine model of mucosal tolerance induction.
    Gerhold K; Avagyan A; Reichert E; Blumchen K; Wahn U; Hamelmann E
    Int Arch Allergy Immunol; 2008; 147(1):25-34. PubMed ID: 18446050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoallergenic derivatives of Fel d 1 obtained by rational reassembly for allergy vaccination and tolerance induction.
    Curin M; Weber M; Thalhamer T; Swoboda I; Focke-Tejkl M; Blatt K; Valent P; Marth K; Garmatiuk T; Grönlund H; Thalhamer J; Spitzauer S; Valenta R
    Clin Exp Allergy; 2014 Jun; 44(6):882-94. PubMed ID: 24552249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fel d 1-derived synthetic peptide immuno-regulatory epitopes show a long-term treatment effect in cat allergic subjects.
    Couroux P; Patel D; Armstrong K; Larché M; Hafner RP
    Clin Exp Allergy; 2015 May; 45(5):974-981. PubMed ID: 25600085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of Fel d 1-derived T-cell peptides on upper and lower airway outcome measurements in cat-allergic subjects.
    Alexander C; Tarzi M; Larché M; Kay AB
    Allergy; 2005 Oct; 60(10):1269-74. PubMed ID: 16134993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive mapping of immune tolerance yields a regulatory TNF receptor 2 signature in a murine model of successful Fel d 1-specific immunotherapy using high-dose CpG adjuvant.
    Leonard C; Montamat G; Davril C; Domingues O; Hunewald O; Revets D; Guerin C; Blank S; Heckendorn J; Jardon G; Hentges F; Ollert M
    Allergy; 2021 Jul; 76(7):2153-2165. PubMed ID: 33345329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-response relationship of specific allergen exposure-induced immunological tolerance: a mouse model.
    Yeh YC; Yen HR; Jiang RS; Wang RC; Huang WC; Chen SC; Lin BS; Liang KL
    Int Forum Allergy Rhinol; 2015 Sep; 5(9):784-93. PubMed ID: 26010206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.